257 results on '"Raffaelli, Bianca"'
Search Results
2. Migräne und Schwangerschaft: Geschlechtsspezifische Aspekte und aktuelles Wissen
3. PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study
4. Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry
5. Health equity, care access and quality in headache – part 2
6. Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
7. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
8. Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence
9. Serum tau protein elevation in migraine: a cross-sectional case–control study
10. Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
11. A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA
12. Long COVID headache
13. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
14. Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
15. Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
16. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors:a randomized placebo-controlled trial
17. Galcanezumab
18. Anti-CGRP basierte Migränemedikamente – eine Übersicht der Studienlage.
19. Migräne in speziellen hormonellen Situationen
20. Migräne und Schwangerschaft
21. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial
22. Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
23. Prevalence and characteristics of rapid eye movement sleep behaviour disorder in adults with migraine: a cross‐sectional screening study.
24. eHealth: Praxistaugliche Angebote in der Schmerzmedizin
25. Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies
26. Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary
27. Galcanezumab
28. Health equity, care access and quality in headache – part 1.
29. Editorial: Spotlight on resistant and refractory migraine
30. Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care Setting
31. Perception of typical migraine images on the internet: Comparison between a metropolis and a smaller rural city in Germany
32. Near‐death experiences are associated with REM sleep intrusion in migraine patients, independent of migraine aura
33. Serum tau protein elevation in migraine: a cross-sectional case- control study
34. A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response
35. Migräne in speziellen hormonellen Situationen
36. Migräne und weibliche Geschlechtshormone
37. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3:topiramate
38. Menstrual migraine is caused by estrogen withdrawal:revisiting the evidence
39. Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura
40. Brain imaging in pregnant women with acute headache
41. The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
42. Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
43. Sex Hormones and Calcitonin Gene–Related Peptide in Women With Migraine
44. Migraine and Hormonal Contraception in Gynecological Outpatient Care—Cross-Sectional Study among Practicing Gynecologists in Germany
45. Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review
46. Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
47. Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination
48. Male and female sex hormones in primary headaches
49. Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents
50. Sex-related differences in frequency and perception of stressful life events during adolescence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.